CIBC Private Wealth Group’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$58.3K Hold
3,480
﹤0.01% 1602
2025
Q1
$47.3K Sell
3,480
-708
-17% -$9.62K ﹤0.01% 1647
2024
Q4
$90K Sell
4,188
-461
-10% -$9.91K ﹤0.01% 1460
2024
Q3
$83.8K Buy
4,649
+38
+0.8% +$685 ﹤0.01% 1566
2024
Q2
$75.4K Buy
4,611
+3,903
+551% +$63.9K ﹤0.01% 1505
2024
Q1
$9.85K Buy
+708
New +$9.85K ﹤0.01% 2283
2019
Q3
Sell
-13,840
Closed -$128K 941
2019
Q2
$128K Sell
13,840
-600
-4% -$5.55K ﹤0.01% 897
2019
Q1
$226K Sell
14,440
-73,100
-84% -$1.14M ﹤0.01% 876
2018
Q4
$1.35M Buy
87,540
+1,000
+1% +$15.4K 0.01% 513
2018
Q3
$1.86M Buy
86,540
+68,600
+382% +$1.48M 0.01% 522
2018
Q2
$436K Buy
17,940
+1,480
+9% +$36K ﹤0.01% 801
2018
Q1
$281K Buy
16,460
+1,959
+14% +$33.4K ﹤0.01% 875
2017
Q4
$275K Buy
14,501
+1,200
+9% +$22.8K ﹤0.01% 879
2017
Q3
$234K Buy
13,301
+1,607
+14% +$28.3K ﹤0.01% 878
2017
Q2
$388K Sell
11,694
-1,538
-12% -$51K ﹤0.01% 559
2017
Q1
$424K Sell
13,232
-7,051
-35% -$226K ﹤0.01% 530
2016
Q4
$735K Sell
20,283
-23,750
-54% -$861K ﹤0.01% 481
2016
Q3
$2.03M Sell
44,033
-786
-2% -$36.2K 0.01% 362
2016
Q2
$2.25M Sell
44,819
-300
-0.7% -$15.1K 0.02% 350
2016
Q1
$2.41M Sell
45,119
-1,960
-4% -$105K 0.02% 332
2015
Q4
$3.09M Buy
47,079
+1,103
+2% +$72.4K 0.02% 311
2015
Q3
$2.6M Buy
45,976
+3,000
+7% +$169K 0.02% 328
2015
Q2
$2.54M Buy
42,976
+4,866
+13% +$288K 0.02% 351
2015
Q1
$2.38M Buy
38,110
+9,993
+36% +$623K 0.02% 357
2014
Q4
$1.62M Buy
28,117
+465
+2% +$26.7K 0.01% 401
2014
Q3
$1.49M Sell
27,652
-10,285
-27% -$553K 0.01% 398
2014
Q2
$1.99M Sell
37,937
-440
-1% -$23.1K 0.02% 366
2014
Q1
$2.05M Buy
+38,377
New +$2.05M 0.02% 362